Once‐daily enoxaparin in pediatric thromboembolism: a dose finding and pharmacodynamics/pharmacokinetics study
Open Access
- 21 May 2007
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 5 (9), 1985-1987
- https://doi.org/10.1111/j.1538-7836.2007.02624.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Use of Low-Molecular-Weight Heparin to Bridge Therapy in Obese Patients and in Patients with Renal DysfunctionPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2006
- How I treat venous thrombosis in childrenBlood, 2006
- Extended enoxaparin monotherapy for acute symptomatic pulmonary embolismVascular Medicine, 2005
- Antithrombotic Therapy in Children*Chest, 2004
- Low-Molecular-Weight Heparin–Induced Thrombocytopenia in a ChildAnnals of Pharmacotherapy, 2004
- The pharmacokinetics and pharmacodynamics of enoxaparin in obese volunteersClinical Pharmacology & Therapeutics, 2002
- Subcutaneous Enoxaparin Once or Twice Daily Compared with Intravenous Unfractionated Heparin for Treatment of Venous Thromboembolic DiseaseAnnals of Internal Medicine, 2001
- Low Molecular Weight Heparin (Enoxaparin) Versus Oral Anticoagulant Therapy (Acenocoumarol) in the Long-Term Treatment of Deep Venous Thrombosis in the Elderly: a Randomized TrialThrombosis and Haemostasis, 2000
- Venographic comparison of subcutaneous low–molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosisJournal of Vascular Surgery, 1999
- Pharmacokinetics of enoxaparin in man given single subcutaneous doses of 1.0-1.25–1.50-2.0 mg/kgThrombosis Research, 1992